Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments that treat this condition

Areas that research this condition

Doctors who treat this condition

edit search filters
Close

Narrow your search

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Reset all filters

Displaying 1-8 out of 8 doctors available

  1. Leif Bergsagel, M.D.

    Leif Bergsagel, M.D.

    1. Internist
    2. Oncologist
    1. Phoenix, Arizona
    Areas of focus:

    Amyloidosis, Monoclonal gammopathy of undetermined significance, Multiple myeloma, Waldenstrom macroglobulinemia more

    see full list in profile
  2. David Dingli, M.D., Ph.D.

    David Dingli, M.D., Ph.D.

    1. Hematologist
    2. Internist
    1. Rochester, Minnesota
    Areas of focus:

    Bone marrow transplant, Peripheral blood stem cell transplant, Amyloidosis, Monoclonal gammopathy of undetermined significance, Multiple myeloma, Paroxysmal nocturnal hemoglobinuria, Plasma cell disorders, POEMS syndrome, Schnitzler syndrome, Waldenstrom macroglobulinemia more

    see full list in profile
  3. Angela Dispenzieri, M.D.

    Angela Dispenzieri, M.D.

    1. Hematologist
    1. Rochester, Minnesota
    Areas of focus:

    Amyloidosis, Cryoglobulinemia, Monoclonal gammopathy of undetermined significance, Multiple myeloma, Osteosclerotic myeloma, POEMS syndrome more

    see full list in profile
  4. Wilson I. Gonsalves, M.D.

    Wilson I. Gonsalves, M.D.

    1. Hematologist
    2. Internist
    3. Oncologist
    1. Rochester, Minnesota
    Areas of focus:

    Amyloidosis, Leukemia, Monoclonal gammopathy of undetermined significance, Multiple myeloma, Plasma cell disorders more

    see full list in profile
  5. Robert A. Kyle, M.D.

    Robert A. Kyle, M.D.

    1. Hematologist
    2. Internist
    1. Rochester, Minnesota
    Areas of focus:

    Amyloidosis, Macroglobulinemia, Monoclonal gammopathy of undetermined significance, Multiple myeloma more

    see full list in profile
  6. Nelson Leung, M.D.

    Nelson Leung, M.D.

    1. Nephrologist
    1. Rochester, Minnesota
    Areas of focus:

    Amyloidosis, Kidney failure, Monoclonal gammopathy of undetermined significance more

    see full list in profile
  7. S. Vincent Rajkumar, M.D.

    S. Vincent Rajkumar, M.D.

    1. Hematologist
    2. Internist
    3. Oncologist
    1. Rochester, Minnesota
    Areas of focus:

    Amyloidosis, Monoclonal gammopathy of undetermined significance, Multiple myeloma more

    see full list in profile
  8. Maria Alice V. Willrich, Ph.D.

    Maria Alice V. Willrich, Ph.D.

    1. Chemist
    1. Rochester, Minnesota
    Areas of focus:

    Inflammatory bowel disease, Monoclonal gammopathy of undetermined significance more

    see full list in profile

Research

Having identified the condition, Mayo Clinic researchers continue to study MGUS to better understand it and to improve treatment options. Specific efforts involve determining risk factors for developing the condition, how these risk factors might influence treatment, and how to prevent progression of MGUS to blood cancers and other conditions.

Doctors and scientists in the Hematologic Malignancies Program of the Mayo Clinic Cancer Center are working on improving the diagnosis and treatment of myeloma and other blood disorders.

Publications

See a list of publications by Mayo Clinic doctors on monoclonal gammopathy of undetermined significance (MGUS) on PubMed, a service of the National Library of Medicine.

Monoclonal gammopathy of undetermined significance (MGUS) care at Mayo Clinic

July 29, 2017

Monoclonal gammopathy of undetermined significance (MGUS)